Refractive outcomes after intravitreal injection of antivascular endothelial growth factor versus laser photocoagulation for retinopathy of prematurity: a meta-analysis

• Published in: BMJ open Vol. 11; no. 2; p. e042384
• Main Authors: Kong, Qihang, Ming, Wai-kit, Mi, Xue-Song
• Format: Journal Article
• Language: English
• Published: England British Medical Journal Publishing Group 10.02.2021; BMJ Publishing Group LTD; BMJ Publishing Group
• Series: Original research
• Subjects: Angiogenesis Inhibitors - therapeutic use; Bevacizumab - therapeutic use; Bias; Child; Developing countries; Drug dosages; Endothelial Growth Factors - therapeutic use; Eye diseases; Humans; Infant; Infant, Newborn; Intravitreal Injections; Laser Coagulation; Lasers; LDCs; Light Coagulation; medical ophthalmology; Meta-analysis; Ophthalmology; paediatric ophthalmology; paediatric surgery; Pediatrics; Retinopathy of Prematurity - drug therapy; Software; Systematic review; Vascular endothelial growth factor; Vascular Endothelial Growth Factor A; Turkey; paediatric surgery; paediatric ophthalmology; medical ophthalmology

ObjectiveTo determine the effects of the intraocular injection of antivascular endothelial growth factor (anti-VEGF) drugs on the refractive status of infants with retinopathy of prematurity (ROP).DesignSystematic review and meta-analysis of the refractive status of infants with ROP who receive anti...